Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Sergey G. Arkhipov has a total of 160 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • First high-resolution structure of the nucleoprotein from the emerging human pathogen Songling virus

    by Alexey Yanshin, Vladimir Pospelov, Egor Ukladov, Vitaliy Tuyrin, Valentin Borshchevskiy, Irina Osinkina, Nikita Radchenko, Yury Ryzhykau, Sergey Arkhipov, Alexander Agafonov, et al.

  • Resolving ambiguity: an integrated approach to bending geometry identification in flexible organic crystals

    by A. S. Dubok, I. S. Tretyakova, A. A. Sonina, S.G. Arkhipov, E. M. Podgorbunskikh, D. A. Rychkov

    The unambiguous identification of all crystallographic faces and directions, including those associated with plastic bending, is a prerequisite for establishing reliable structure–property relationships in flexible organic crystals. Conventional face indexing via single-crystal X-ray diffraction (SCXRD) is often compromised by the morphological imperfections typical for these materials and the technical limitations of diffractometer on-axis optical microscopes. This work introduces and validates an integrated analytical protocol that synergistically combines computational morphology prediction, precise interfacial angle measurement via scanning electron and optical microscopy, and directed SCXRD indexing enhanced by internal (crystal bend) and external (mount) geometric standards. Applied to the plastically bendable crystals of α-pyrazinamide, 1,3,5-trichlorobenzene and L-leucinium hydrogen maleate, this multi-technique framework conclusively resolved their bending geometries, identifying the primary bending faces and directions as (002)/[100], {011}/[100] and (20 1 )/[010], respectively. Crucially, while the bending plane can be identified via SCXRD standards alone, the full protocol is mandatory for determining all morphological faces, providing the complete dataset essential for computational analysis and predictive model building. This workflow overcomes the ambiguities inherent to any single method and provides a robust, generalizable framework for the reliable morphology characterization of mechanically flexible molecular crystals.


  • Open Access

    Molecular Mimicry by the Tick-Borne Encephalitis Virus E Protein: A Hidden Link to Autoimmunity

    by Anna M. Timofeeva, Ksenia S. Aulova, Yana S. Ulyanova, Mark M. Melamud, Sergey G. Arkhipov, Elena I. Krasnova, Georgy A. Nevinsky

    In this study, we combined computational predictions with experimental validation as a hybrid strategy to explore whether the E protein of tick-borne encephalitis virus (TBEV) possesses autoimmune potential. Using in silico homology searches, we identified two viral epitopes (evglekl and vtgtqgt) within the TBEV E protein that share sequence identity with fragments of the human proteins DNAH7 and CSMD2. Antibodies against these epitopes were detected in the plasma of a subset of patients after natural TBEV infection. Notably, no such antibodies were found in recipients of the Tick-E-Vac vaccine, indicating that the current vaccine does not induce cross-reactive humoral responses to these epitopes. Further computational analysis predicted that these epitopes could be presented by HLA class II molecules (alleles DRB1*09:01 and DRB1*07:01), which are known to be associated with autoimmune pathologies. Molecular dynamics simulations confirmed stable binding of the peptides within the HLA grooves, with favorable binding energies. These findings suggest a possible involvement of T-helper cells in the autoreactive process. Natural TBEV infection can give rise to antibodies against epitopes homologous to human proteins, particularly in genetically predisposed hosts. While such homology alone does not predict the onset of autoimmune disease, it represents a risk factor.


  • Preparation and powder X-ray diffraction study of tecovirimat hydrate solid forms

    by Alexander Ivlev, Dmitry Kolybalov, Sergey Arkhipov, Ok Ton Dyan, Pavel Zaikin

    Tecovirimat [ST-246; systematic name: N -(3,5-dioxo-4-azatetracyclo[5.3.2.0 2,6 .0 8,10 ]dodec-11-en-4-yl)-4-(trifluoromethyl)benzamide monohydrate, C 19 H 15 F 3 N 2 O 3 ] is an essential antiviral drug used against orthopoxviruses, yet its solid-state landscape remains only partially characterized. Here we identify experimental conditions enabling the reproducible crystallization of three hydrated forms reported in the patent literature: two monohydrates ( I and III ) and one hemihydrate ( V ). The phase purity of all samples was confirmed by Rietveld refinement of the powder X-ray diffraction patterns. The single-crystal structures of forms I and V were determined for the first time, whereas the structure of monohydrate III was redetermined at 293 K to allow direct comparison under identical conditions.


  • Synthesis of Heterocyclic Chalcone Analogues Containing Chromene and 1-Hydroxyimidazole Moieties

    by Elizaveta I. Basanova, Ekaterina M. Kulinich, Ivan A. Moskalev, Alexey Yu. Fedorov, Sergey G. Arkhipov, Ol’GA I. Yarovaya, Polina A. Nikitina

    Hybrid chalcones containing 1-hydroxyimidazole and chromene moieties were synthesized from 5-acetyl-1-hydroxyimidazoles and 3-formylchromenes. Application of DBU as a catalyst led to the mixtures of the target chalсones and intermediate aldols. Further interaction of the mixtures with 40% aqueous solution of sodium hydroxide in ethanol resulted in pure chalсones, isolated as trans-isomers. According to X-ray single crystal diffraction analysis, (E)-3-{3-[2-(4-fluorophenyl)-1-hydroxy-4-methyl-1H-imidazol-5-yl]-3-oxoprop-1-en-1-yl}-6-methyl-4H-chromen-4-one exists as an N-hydroxyimidazole tautomer. Its planar structure is stabilized by the intramolecular hydrogen bond between the N-hydroxy group of the imidazole and the adjacent carbonyl group. The (E)-3-{3-[2-(4-fluorophenyl)-1-hydroxy-4-methyl-1H-imidazol-5-yl]-3-oxoprop-1-en-1-yl}-6-methyl-4H-chromen-4-one molecules in crystal were head-to-tail packed.

  • Synthesis, structure investigation and evaluation of anti-orthopoxvirus activities of 2-(2-arylethenyl)imidazoles

    by Vladislav O. Golfarb-Abramov, Anastasia V. Kazennova, Elizaveta Ivanovna Basanova, Olga A. Serova, Nikolai I. Bormotov, Larisa N. Shishkina, Vyacheslav I. Krasnov, Dmitriy N. Polovyanenko, Ivan A. Moskalev, Alexey Yu. Fedorov, et al.

    Structural features (isomers, tautomers, conformers) of N -substituted 2-(2-arylethenyl)imidazoles were considered. Antiviral activity against orthopoxviruses was evaluated, with 1-methoxyimidazoles being the most promising compounds.


  • Open Access

    Structural Features of Nucleoproteins from the Recently Discovered Orthonairovirus songlingense and Norwavirus beijiense

    by Alexey O. Yanshin, Daria I. Ivkina, Vitaliy Yu. Tuyrin, Irina A. Osinkina, Anton E. Tishin, Sergei E. Olkin, Egor O. Ukladov, Nikita S. Radchenko, Sergey G. Arkhipov, Yury L. Ryzhykau, et al.

    The recent discovery of Orthonairovirus songlingense (SGLV) and Norwavirus beijiense (BJNV) in China has raised significant concern due to their potential to cause severe human disease. However, little is known about the structural features and function of their nucleoproteins, which play a key role in the viral life cycle. By combining small-angle X-ray scattering (SAXS) data and AlphaFold 3 simulations, we reconstructed the BJNV and SGLV nucleoprotein structures for the first time. The SGLV and BJNV nucleoproteins have structures that are broadly similar to those of Orthonairovirus haemorrhagiae (CCHFV) nucleoproteins despite low sequence similarity. Based on structural analysis, several residues located in the positively charged region of BJNV and SGLV nucleoproteins have been indicated to be important for viral RNA binding. A positively charged RNA-binding crevice runs along the interior of the SGLV and BJNV ribonucleoprotein complex (RNP), shielding the viral RNA. Despite the high structural similarity between SGLV and BJNV nucleoprotein monomers, their RNPs adopt distinct conformations. These findings provide important insights into the molecular mechanisms of viral genome packaging and replication in these emerging pathogens. Also, our work demonstrates that experimental SAXS data can validate and improve predicted AlphaFold 3 structures to reflect their solution structure and also provides the first low-resolution structures of the BJNV and SGLV nucleoproteins for the future development of POC tests, vaccines, and antiviral drugs.


  • Open Access

    The Use of Heterologous Antigens for Biopanning Enables the Selection of Broadly Neutralizing Nanobodies Against SARS-CoV-2

    by Vazirbek S. Aripov, Anna V. Zaykovskaya, Ludmila V. Mechetina, Alexander M. Najakshin, Alexander A. Bondar, Sergey G. Arkhipov, Egor A. Mustaev, Margarita G. Ilyina, Sophia S. Borisevich, Alexander A. Ilyichev, et al.

    Background: Since the emergence of SARS-CoV-2 in the human population, the virus genome has undergone numerous mutations, enabling it to enhance transmissibility and evade acquired immunity. As a result of these mutations, most monoclonal neutralizing antibodies have lost their efficacy, as they are unable to neutralize new variants. Antibodies that neutralize a broad range of SARS-CoV-2 variants are of significant value in combating both current and potential future variants, making the identification and development of such antibodies an ongoing critical goal. This study discusses the strategy of using heterologous antigens in biopanning rounds. Methods: After four rounds of biopanning, nanobody variants were selected from a phage display library. Immunochemical methods were used to evaluate their specificity to the S protein of various SARS-CoV-2 variants, as well as to determine their competitive ability against ACE2. Viral neutralization activity was analyzed. A three-dimensional model of nanobody interaction with RBD was constructed. Results: Four nanobodies were obtained that specifically bind to the receptor-binding domain (RBD) of the SARS-CoV-2 spike glycoprotein and exhibit neutralizing activity against various SARS-CoV-2 strains. Conclusions: The study demonstrates that performing several rounds of biopanning with heterologous antigens allows the selection of nanobodies with a broad reactivity spectrum. However, the fourth round of biopanning does not lead to the identification of nanobodies with improved characteristics.


  • Open Access

    Anti-Orthopoxvirus Activity of Amantadine and Rimantadine Derivatives—In Vitro Testing and Molecular Modeling

    by Ivan A. Moskalev, Ekaterina A. Akishina, Evgenij A. Dikusar, Olga I. Yarovaya, Sophia S. Borisevich, Edward M. Khamitov, Alexey Yu. Fedorov, Sergey G. Arkhipov, Nikolay I. Bormotov, Olga A. Serova, et al.

    In 2022, the number of mpox cases spiked worldwide, leading to a surge in scientific research on members of the Orthopoxvirus genus and the discovery of new compounds exhibiting anti-orthopoxvirus activity. This work is devoted to the synthesis of compounds containing an adamantane fragment and the evaluation of their activity against the vaccinia virus, offering a possible mechanism of the antiviral action of the synthesized agents. Among all the studied adamantane derivatives, three compounds (2, 4, and 12) were found to demonstrate the highest antiviral activity, with the most promising compound 2 (N-(adamantan-1-yl)isonicotinamide) having the lowest toxicity level with a selectivity index (SI) of 115. The pharmacophoric profiles of these compounds are similar to the pharmacophoric profile of tecovirimat, an inhibitor of the membrane viral protein p37. Analysis of the results of molecular modeling suggests that the investigated compounds can inhibit the vaccinia virus by suppressing the phospholipase activity of membrane viral protein p37.


  • 2-Aryl-1-hydroxyimidazoles possessing antiviral activity against a wide range of orthopoxviruses, including the variola virus

    by Elizaveta I. Basanova, Ekaterina A. Kulikova, Nikolai I. Bormotov, Olga A. Serova, Larisa N. Shishkina, Alyona S. Ovchinnikova, Dmitry A. Odnoshevskiy, Oleg V. Pyankov, Alexander P. Agafonov, Olga I. Yarovaya, et al.

    Scientific interest in orthopoxvirus infections and search for new highly effective compounds possessing antiviral activity against orthopoxviruses have significantly increased as a result of worldwide mpox outbreak in 2022. The present work deals with the synthesis of new 2-arylimidazoles exhibiting in vitro activity not only against the vaccinia virus, cowpox virus and ectromelia (mousepox) virus but also against the variola virus. Among the imidazole derivatives under consideration (1-hydroxyimidazoles, 1-methoxyimidazoles, 1-benzyloxyimidazoles, and imidazole N-oxides), the most promising antiviral activity is demonstrated by 1-hydroxyimidazoles, which may exist as two prototropic tautomers. Both of these tautomers may be manifested in different crystal structures of these compounds, according to single-crystal X-ray diffraction analysis, while predominantly one of them (N-hydroxy-tautomeric form) is present in DMSO-d6 solutions and in the gaseous state, as shown by NMR spectroscopy and quantum-chemical calculations. The leader compound 1-hydroxy-2-(4-nitrophenyl)imidazole 4a demonstrated the highest selectivity indices against the vaccinia virus (SI = 1072) and the variola virus (SI = 373).